Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6276350 | 0.85 | HPRT1 (0.39) | ALDH1A1HPRT1 | |
| SCHEMBL9958334 | 0.77 | ALDH1A1 (0.42) | ALDH1A1HPRT1 | |
| SCHEMBL6009685 | 0.77 | PTGER1 (0.36) | — | |
| SCHEMBL2593632 | 0.74 | HPGD (0.41) | ALDH1A1 | |
| SCHEMBL11711823 | 0.74 | ALDH1A1 (0.46) | ALDH1A1 | |
| SCHEMBL2591778 | 0.72 | GPR3 (0.45) | ALDH1A1 | |
| SCHEMBL2590610 | 0.72 | HPRT1 (0.50) | ALDH1A1HPRT1 | |
| SCHEMBL18317448 | 0.70 | KDM4E (0.46) | ALDH1A1 | |
| SCHEMBL815764 | 0.70 | HPRT1 (0.46) | ALDH1A1HPRT1 | |
| SCHEMBL5964895 | 0.70 | HPRT1 (0.52) | ALDH1A1HPRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109311844-B | Triazine compound, method for producing same, and organic electroluminescent element containing same as constituent component | 东曹株式会社 | 2021-07-20 | — | — | CN | disclosed |
| US-9269911-B2 | Organic light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2016-02-23 | — | — | US | disclosed |
| EP-2564441-A1 | ORGANIC LIGHT-EMITTING DEVICE | Canon Kabushiki Kaisha (JP) | 2013-03-06 | — | — | EP | disclosed |
| US-20130037791-A1 | ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2013-02-14 | — | — | US | disclosed |
| WO-2011136156-A1 | ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2011-11-03 | — | — | WO | disclosed |